SLAB — Silicon Laboratories Income Statement
0.000.00%
Last trade - 00:00- $3.34bn
- $2.95bn
- $584.39m
- 49
- 26
- 36
- 30
Annual income statement for Silicon Laboratories, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
R2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | |
|---|---|---|---|---|---|
| Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 511 | 1,024 | 721 | 782 | 584 |
| Cost of Revenue | |||||
| Gross Profit | 295 | 643 | 425 | 461 | 312 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 622 | 905 | 757 | 806 | 750 |
| Operating Profit | -111 | 119 | -36.2 | -24.2 | -165 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -132 | 126 | -58.2 | -10.5 | -155 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -118 | 88 | -71.6 | -18.5 | -191 |
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 12.5 | 91.4 | 2,117 | -34.5 | -191 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 12.5 | 91.4 | 2,117 | -34.5 | -191 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.56 | 2.61 | -1.3 | -1.09 | -5.73 |